28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Clinical trial NCT02531152 · COMPLETED
Trial details
- NCT number
- NCT02531152
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-04-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.